Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.37 -0.02 (-5.13%)
At close: Nov 10, 2026 · 4:00 PM EST

Tenaya Therapeutics (TNYA) Preferred Stock Liabilities (2020 - 2021)

Updated

Tenaya Therapeutics' Preferred Stock Liabilities came in at $240.74 million for Q2 2021, up 132.1% from $103.71 million a year earlier and unchanged from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Tenaya Therapeutics' Preferred Stock Liabilities was $220.75 million.

  • Business Quant data shows TNYA's Preferred Stock Liabilities at $240.74 million (Q1 2021), $220.75 million (Q4 2020) and $135.04 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tenaya Therapeutics 84.33 Mn 17.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 220.75 Mn
Jun 30, 2021 240.74 Mn
Mar 31, 2021 240.74 Mn
Dec 31, 2020 220.75 Mn
Sep 30, 2020 135.04 Mn
Jun 30, 2020 103.71 Mn
API Access

Tenaya Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TNYA&period=max&api_key=YOUR_API_KEY